REGAN KENDREGAN: Open Payments
NPI 1356488621 · KANKAKEE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 19 payments from 9 companies in 2025. Trend: 2023 $416 · 2024 $902 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Novo Nordisk Inc | 3 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| Amgen Inc. | 3 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $33 |
| Boston Scientific Corporation | 1 | $22 |
| HARMONY BIOSCIENCES LLC | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: JARDIANCE, FARXIGA, EVENITY, Ozempic, Kerendia, MOUNJARO, BREZTRI, WATCHMAN Access System.
Industry payments across IL — which companies pay providers there.
